Premier Perspectives The blog for insider insights in clinical development Clinical Research: Phase 1 - Phase 4 Getting It Right from the Start: 10 Essentials for Designing Biomarker-Guided Oncology Clinical Studies By Ashley Herrick October 20, 2023 Featured Posts Clinical ResearchPhase 1 - Phase 4 Operationalizing Biomarker-Guided Oncology Trials: Planning for Success By Ashley Herrick October 17, 2023 Clinical ResearchPhase 1 - Phase 4 Maximizing Oncology Study Outcomes: Overcoming Enrollment Challenges in a Phase 2 Prostate Cancer Clinical Trial By Ashley Herrick May 3, 2022 Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 Maximizing Oncology Study Outcomes: Protocol Development Considerations By Ashley Herrick January 25, 2022 Clinical ResearchPhase 1 - Phase 4 Empowering Oncology Patients: Recruitment and Retention Strategies for Optimizing Study Outcomes By Ashley Herrick January 17, 2022 Clinical ResearchPhase 1 - Phase 4 A Primer on Cancer Immunotherapy Part 2: The Cancer Immune Response & Mechanisms of Resistance By Ashley Herrick August 12, 2021 Clinical ResearchPhase 1 - Phase 4 A Primer on Cancer Immunotherapy Part 1: Goals & Major Approaches By Ashley Herrick August 10, 2021 Clinical ResearchPhase 1 - Phase 4 Introduction to CAR T-Cell Therapy Part 2: Additional Considerations & Future Opportunities By Ashley Herrick July 15, 2021 Clinical ResearchPhase 1 - Phase 4 Introduction to CAR T-Cell Therapy Part 1: Background & Current Development Landscape By Ashley Herrick July 13, 2021 × ALSO OF INTERESTPremier Research Enhances Oncology...PREMIER VOICES #15: Enhancing Clinical Trial...Proventa Oncology Strategy Meeting East Coast USA 2022
